坦雷注射对多种耐药生物体的影响:一个测试负的病例控制研究和网络药理学分析
Wen Wang1, Jiayue Xu1, Qinhuai Lai1
1Institute of Integrated Traditional Chinese and Western Medicine, Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, 610041, China; Sichuan Center of Technology Innovation for Real World Data, Chengdu, China.
概括
坦雷 (TRQ) 注射可能会降低在重症监护室 (ICU) 患有抗卡巴尼姆的克莱布西拉肺炎 (CRKP) 感染的风险. 这项研究探讨了TRQQ.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 多药耐药生物 (MDROs) 是重症监护室 (ICU) 的一个重大威胁.
- 坦雷青 (TRQ) 注射对MDROs在现实临床环境中的有效性仍未得到充分研究.
- 现有的体外数据表明TRQ的潜在抗菌活性.
研究的目的:
- 研究在ICU患者中注射Tanreqing (TRQ) 的治疗模式.
- 评估TRQ在与抗生素一起使用时对抗MDRO感染的实际有效性.
主要方法:
- 通过使用大型的多中心ICU数据库,进行了一项真实世界,测试负的病例控制研究.
- 分析了感染特定MDROs (例如MRSA,CRAB,VRE,CRPA,CRE,CRKP) 或抗生素敏感菌株的患者.
- 边缘结构模型被用来控制时间变化的混因素,网络药理学被用来探索作用机制.
主要成果:
- 包括2890名患者中的一半以上接受了TRQ注射抗生素,持续时间可变.
- TRQ注射与抗卡巴胺耐药Enterobacter sp.的可能性降低有关. (CRE) 和耐卡巴尼姆的克莱布西拉肺炎 (CRKP) 感染.
- 网络药理学表明TRQ可以通过改变代谢途径和抑制β-乳酸酶来对抗CRKP.
结论:
- 在ICU中注射Tanreqing (TRQ) 的使用与CRKP感染的风险降低有关.
- 研究结果表明,TRQ可能调节β-乳糖抗生素耐药性和代谢途径,有助于其有效性.
- 需要进一步的研究,以充分阐明TRQ在治疗MDRO感染中的作用.
相关概念视频
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771


